Product development centered on beauty and health
First written in FY2016. 40 of 50 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-10-08.
63 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In February 2026, the company launched Curvaceous Etavely (カーヴィシャスエターヴェリー), a new series of its flagship Curvaceous (カーヴィシャス) product.」
The company launched a new series of its flagship Curvaceous product in February 2026, expanding its product lineup. - FY2026-H1AdvancedAnnual report
「In April 2025, the company launched mon marier cherire silver (モンマリエシェリルシルバー), a limited-quantity new color of its flagship mon marier cherire (モンマリエシェリル) series; in May, Kales Warm Pink (カレスウォームピンク), a limited-quantity new color of Curvaceous Kales (カーヴィシャスカレス); and in August, Idelat Indigo Navy (イデラインディゴネイビー), a limited-quantity new color of Decorte Lumiés Idelat (デコルテ リュミエス イデラ).」
In April, May and August 2025, the company successively launched limited-edition new colors for its flagship shapewear series, expanding its product lineup. - FY2025-H1AdvancedAnnual report
「In terms of product development, sales of Liberdigne Pink (リベルディーニュ ピンク), launched in June 2024 as a limited-quantity product, exceeded expectations. In addition to beginning to offer it as a standard color rather than on a limited-quantity basis, sales of the new Iderat Violet (イデラヴァイオレット) color of Decorte Lumiés Idelat (デコルテ リュミエス イデラ), launched in August of the same year as a limited-quantity product, continued at a pace above the sales plan. Sales of the shapewear lingerie line Maquigeriec (マキジェリーク) also remained strong, supported by the introduction of new colors and an expanded product lineup, and revenue from the series increased 35.9% year on year.」
The company made Liberdigne Pink a standard color, introduced a new color for Decorte Lumiés Idelat, and added new colors and products to Maquigeriec. Maquigeriec revenue increased 35.9% year on year. - FY2024AchievedAnnual report
「Furthermore, the launch in January 2024 of Liberdigne (リベルディーニュ), the first new product in 11 years, led to a substantial increase in sales in the fourth quarter.」
Liberdigne, the successor series to the flagship product that had previously been described as a planned launch, was launched in January 2024. - FY2024-Q3AdvancedAnnual report
「Ahead of the 20 January 2024 launch of Liberdigne (リベルディーニュ), a new product and successor series to the flagship Bel-Age Avance Sakura (ベルアージュ アヴァンセ サクラ), the first such launch in 11 years」
The company is proceeding with plans to launch Liberdigne, the successor series to its flagship product, on 20 January 2024. This represents concrete progress in product development, with the introduction of a successor series for the first time in 11 years. - FY2024-Q2AdvancedAnnual report
「Sales of shapewear remained solid, helped by the launch in August 2023 of a new product, Decorte Lumiés Idelat (デコルテ リュミエス イデラ), from the flagship series, which was well received.」
A new product from the top-tier shapewear series was launched in August 2023 and was well received. This demonstrates concrete progress in expanding the product lineup centered on beauty and health. - FY2024-Q1RestatedAnnual report
「Research and development expenses for the cumulative first quarter of the consolidated fiscal year amounted to ¥2 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
Research and development activities have continued, with expenses of ¥2 million in the cumulative first quarter. It stated that there were no material changes in the status of these activities. - FY2023AdvancedAnnual report
「In February 2023, the company launched a new product in its flagship shapewear core series, which was well received, and introduced many other new and limited-edition products.」
The company launched a new product in its core series in February 2023 and continued introducing new and limited-edition products. It explained that original supplements, orthotics and dedicated footwear also contributed to strengthening its earnings base. - FY2023-Q2AdvancedAnnual report
「During the first six months of the fiscal year, limited-edition colors of shaping underwear were well received. In addition to demand ahead of announced price increases for some products from October, subscriptions to the original M.B.M.S(マルコビューティメイクサプリメント) supplement progressed steadily. At MARUKO ASSE(オーダーメイドインソール及び専用シューズ), the number of male customers increased alongside female customers. As a result of developing new customers, both revenue and profit exceeded plan.」
The Company said that progress in limited-edition colors of body-shaping lingerie, subscriptions for M.B.M.S and the development of male customers for MARUKO ASSE enabled the expanded product and service lineup to drive sales and profit above plan. - FY2022AdvancedAnnual report
「In addition to launching well-received new colors and limited-quantity products in core body-shaping lingerie, subscription purchases of the original supplement became established and sales rose sharply. The Company also launched original shoes designed exclusively for Orthotics custom insoles, resulting in increases in both revenue and profit compared with the previous fiscal year.」
The women’s lingerie-related business expanded new colors and limited-edition products in body-shaping lingerie, subscriptions for the original supplement, and shoes designed exclusively for Orthotics, resulting in increases in both revenue and profit. - FY2022-Q3AdvancedAnnual report
「In product development, we sold the limited-edition Chadal Gray color of the Decorte Lumiés body-shaping lingerie series, which was well received. Sales also progressed favorably as new sales and subscriptions for the original supplement grew. As a result, revenue increased during the nine months ended December 31. Net sales were ¥11,974 million, up 4.9% year on year, while segment profit was ¥408 million, down 13.1%.」
The Company launched a limited-edition color of body-shaping lingerie and expanded new sales and subscriptions for the original supplement. The women’s lingerie and related business generated net sales of ¥11,974 million, up 4.9% year on year. - FY2022-Q2AdvancedAnnual report
「In product development, we sold the limited-edition Curvaceous Premier Blue color in our core body-shaping lingerie. The product was well received, and sales of the doctor-supervised original supplement M.B.M.S progressed favorably, including new sales and subscriptions, amid rising health awareness. As a result, product sales progressed steadily and the Company achieved increases in both revenue and profit.」
The Company launched a limited-edition color of body-shaping lingerie and expanded new sales and subscriptions for doctor-supervised M.B.M.S. The women’s lingerie and related business achieved increases in both revenue and profit. - FY2022-Q1AdvancedAnnual report
「Sales of limited-period color products in core body-shaping lingerie were well received. As health awareness increased, sales of M.B.M.S, an original supplement supervised by a doctor, steadily grew. The Company advanced the launch of new products and expansion of its lineup.」
The Company launched limited-period color products, expanded sales of doctor-supervised M.B.M.S, and advanced the launch of new products and expansion of its product lineup. - FY2021AdvancedAnnual report
「The new business M.B.M.S (Maruko Beauty Make Supplement), which we began selling, made a steady start as it progressed from test marketing toward full-scale rollout, and we expanded our product lineup and services.」
The Company advanced M.B.M.S from test marketing to full-scale rollout and expanded new products and services. R&D expenses were ¥43.9 million, and acquired trademarks totaled 106. - FY2021-Q3AdvancedAnnual report
「In November 2020, we added new items to Decorte Lumiés and launched the new Orangish Pink color, while also launching the new Anemolle Navy color of corps changer voir. The expanded product lineup resulted in higher revenue year on year.」
In November 2020, the Company added new items to existing products and launched 2 new colors, expanding its product lineup. Revenue in the women’s lingerie-related business increased year on year. - FY2021-Q2AdvancedAnnual report
「As various promotions proved effective, the number of middle-aged customers increased. In August 2020, we launched limited-edition new colors of Belleages Avance Sakura for this age group, Belleages Avance Sakura Creir Red/Creir Brown. The product received many orders and was almost sold out by the end of the following month, September, receiving an extremely favorable response.」
The Company launched limited-edition new colors for middle-aged customers in August 2020, and they were almost sold out by the end of September. This indicates concrete progress in developing and launching products suited to the customer base. - FY2021-Q1AdvancedAnnual report
「During the first quarter, we expanded products that can become new sources of revenue by launching the Mon Marier Cherire Blue spot color for the bridal series mon marier and Eclajou, a new-concept body-makeup lingerie product that shifts the focus from “concealing” to “showcasing.”」
The Company launched a new color of mon marier and Eclajou, a new-concept body-makeup lingerie product, expanding the lineup of products that can become new sources of revenue. - FY2020AdvancedAnnual report
「In product development, we launched the Glass Black new color of Belleages Avance Sakura, a core body-shaping lingerie product, in August 2019; the Oia Cream new color of Curvaceous in November of the same year; and Toujoucelle, a new product series for senior customers, in January 2020. All contributed favorably to revenue.」
The Company launched new colors and a new body-shaping lingerie product series in August and November 2019 and January 2020, respectively, and said that each contributed to revenue. - FY2020-Q3AdvancedAnnual report
「In product development, we launched the limited-edition Oia Cream color of the Curvaceous series and the Neon Pink color of m-fit sports active, women’s sports underwear. We also expanded the product lineup into new sources of revenue, including GemsBeauty makeup cosmetics produced by makeup artist Kenichi Ogura, known as “Ogunee,” and Orthotics, which pursues beauty by shaping the feet with high-functionality custom insoles.」
The Company launched limited-edition and new colors of core products and expanded its product lineup into new sources of revenue, including makeup cosmetics and high-functionality custom insoles. - FY2020-Q2AdvancedAnnual report
「During the six months ended September 30, we expanded the product lineup by launching the limited-edition Marble Emerald color of Decorte Lumiès and the limited-edition Glass Black color of Belleages Avance Sakura for middle-aged customers. Sales of our core body-shaping lingerie progressed steadily, and we also began offering Orthotics, a product that pursues beauty by shaping the feet with high-functionality custom insoles.」
The Company launched 2 limited-edition colors of body-shaping lingerie and began offering Orthotics, high-functionality custom insoles, thereby expanding its product lineup. - FY2020-Q1AdvancedAnnual report
「During the first quarter, the supply system for the core Curvaceous series stabilized, while the bridal body-makeup lingerie series mon marier was renewed for the first time in 11 years. The product lineup was steadily expanded.」
In addition to stabilizing Curvaceous supplies, the Company renewed its core bridal product for the first time in 11 years, expanding its product lineup. - FY2019RestatedAnnual report
「Based on our management philosophy of pursuing beauty of the mind, body and figure, we are actively developing products that offer new added value suited to increasingly diverse customer age groups and consumer values. In addition to high body-shaping functionality and outstanding design, we are focusing on product development in new fields centered on women’s beauty and health. As of the end of the fiscal year, acquired intellectual property comprised 1 patent and 91 trademarks, while R&D expenses were ¥21.677 million.」
The product development policy continues to address beauty and health, body-shaping functionality, design and diverse customer needs. R&D expenses were ¥21.677 million, and acquired intellectual property comprised 1 patent and 91 trademarks. - FY2019-Q3RestatedAnnual report
「R&D expenses for the nine months ended December 31 were ¥15 million. There were no material changes in the Group’s R&D activities during the nine months ended December 31.」
R&D activities continued, with expenses of ¥15 million reported for the nine months ended December 31. There were no material changes in the activities. - FY2019-Q2AdvancedAnnual report
「In product development, Hip Up Pants, which underwent a test sale in June, sold out immediately following favorable customer response. After becoming a standard product and being offered again from September, the initial additional run of 2,000 units sold out by reservation, again receiving favorable reviews. Continued popularity is expected in the second half and beyond. Cosmetics and supplements were also made standard products, steadily expanding the product lineup.」
Hip Up Pants became a standard product after its test sale, and the additional 2,000 units sold out by reservation. Cosmetics and supplements were also made standard products. - FY2019-Q1AdvancedAnnual report
「In June 2018, we conducted a test sale of 2,000 units of Hip Up Pants at 29 stores. The product sold out on the day of launch and received favorable reviews, so we decided to make it a standard product from this autumn. We also decided to make cosmetics and supplements standard products, steadily expanding our product lineup.」
The 2,000-unit test sale at 29 stores sold out on the day of launch, and the product was made a standard offering from autumn. Cosmetics and supplements were also made standard products. - FY2018-Q3AdvancedAnnual report
「In the women’s lingerie and related business segment, we began taking reservations on 24 November 2017 for Curvaceous, the successor to our core body-shaping lingerie series Carille, as we worked to provide products that meet customer needs. Curvaceous retains the same functionality, including its body-shaping capability, while evolving to offer greater ease of wear and comfort. It received favorable reviews from many customers and made a strong start as a core series. We also developed and launched new series products, including cosmetics and supplements, with the aim of creating new sources of revenue, and each got off to a strong start.」
Reservations for Curvaceous, the successor to the core product Carille, began on 24 November 2017, and the product made a strong start. The Company also developed and launched new series of cosmetics and supplements, which likewise got off to a strong start. - FY2018-Q2RestatedAnnual report
「R&D expenses for the six months ended September 30 were ¥7 million. There were no material changes in the Group’s R&D activities during the six months ended September 30.」
R&D activities continued, with expenses of ¥7 million reported for the six months ended September 30. There were no material changes in the activities. - FY2018-Q1RestatedAnnual report
「Expanding purchase opportunities by expanding new products and services and offering new sales methods」
The policy of expanding purchase opportunities through an expanded range of new products and services has been reaffirmed as one initiative under the Maruko Reborn Project. - FY2017RestatedAnnual report
「The Group’s R&D activities are based on our management philosophy of pursuing beauty of the mind, body and figure. In addition to high body-shaping functionality and outstanding design, we are actively developing products that offer new added value suited to increasingly diverse customer age groups and consumer values, with a focus on new fields centered on women’s beauty and health.」
The product development policy continues to address beauty and health, high body-shaping functionality, design and diverse customer needs. R&D expenses were ¥14.4 million, and acquired intellectual property comprised 1 patent and 101 trademarks. - FY2017-Q3AdvancedAnnual report
「As part of our product initiatives, in November we launched the winter tights LEGMAKING WARBLE by.SYMMETRY, made with germanium and highly elastic polyurethane yarns and featuring a lift-up function. In December, we launched BALANCE SYMMETRY, an outerwear-style item designed to make a well-balanced body look even more attractive.」
In November and December, the Company launched 2 new products related to beauty, health and body shaping. - FY2017-Q1AdvancedAnnual report
「In June, we launched two products on a limited-quantity basis: the summer product LEGMAKING COLTO for leg shaping and LEGMAKING SYMMETRY, which features a lift-up adjustment function.」
The Company launched 2 new body-shaping products on a limited-quantity basis in June, providing a concrete example of product development and commercialization. - FY2016First statedAnnual report
「Based on our management philosophy of pursuing beauty of the mind, body and figure, we are actively developing products that offer new added value suited to increasingly diverse customer age groups and consumer values. In addition to high body-shaping functionality and outstanding design, we are focusing on product development in new fields centered on women’s beauty and health.」
Product development is advancing in response to body-shaping needs and design preferences, as well as women’s beauty and health and diverse customer age groups and values. R&D expenses were ¥14.4 million, and acquired intellectual property comprised 1 patent and 96 trademarks.